| Literature DB >> 11377180 |
G Brooks1, W Burgess, D Colthurst, J D Hinks, E Hunt, M J Pearson, B Shea, A K Takle, J M Wilson, G Woodnutt.
Abstract
A novel series of mutilin 14-carbamates has been discovered as a result of structure-activity studies on the naturally occurring antibiotic pleuromutilin (1). In particular, the 4-methoxybenzoylcarbamate, SB-222734 (15o) displays potent antibacterial activity against a number of bacterial pathogens which are resistant to currently used agents and shows enhanced metabolic stability when compared to earlier pleuromutilin derivatives. Such derivatives therefore have the potential to provide a new class of antibacterial agents for human therapy which address the threat of bacterial resistance.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11377180 DOI: 10.1016/s0968-0896(00)00338-2
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641